GB0107751D0 - Pharmaceutically active compounds - Google Patents

Pharmaceutically active compounds

Info

Publication number
GB0107751D0
GB0107751D0 GBGB0107751.0A GB0107751A GB0107751D0 GB 0107751 D0 GB0107751 D0 GB 0107751D0 GB 0107751 A GB0107751 A GB 0107751A GB 0107751 D0 GB0107751 D0 GB 0107751D0
Authority
GB
United Kingdom
Prior art keywords
active compounds
pharmaceutically active
pharmaceutically
compounds
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0107751.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Pfizer Inc
Original Assignee
Pfizer Ltd Great Britain
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain, Pfizer Inc filed Critical Pfizer Ltd Great Britain
Priority to GBGB0107751.0A priority Critical patent/GB0107751D0/en
Publication of GB0107751D0 publication Critical patent/GB0107751D0/en
Priority to US10/099,264 priority patent/US6794387B2/en
Priority to PCT/IB2002/000854 priority patent/WO2002079203A1/en
Priority to MXPA03005990A priority patent/MXPA03005990A/es
Priority to AU2002241211A priority patent/AU2002241211A1/en
Priority to BR0208463-5A priority patent/BR0208463A/pt
Priority to JP2002577827A priority patent/JP2004528320A/ja
Priority to EP02707056A priority patent/EP1395589A1/en
Priority to CA002442329A priority patent/CA2442329A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0107751.0A 2001-03-28 2001-03-28 Pharmaceutically active compounds Ceased GB0107751D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0107751.0A GB0107751D0 (en) 2001-03-28 2001-03-28 Pharmaceutically active compounds
US10/099,264 US6794387B2 (en) 2001-03-28 2002-03-14 Pharmaceutically active compounds
PCT/IB2002/000854 WO2002079203A1 (en) 2001-03-28 2002-03-19 Imidazo-triazine derivatives as pde 5 inhibitors
MXPA03005990A MXPA03005990A (es) 2001-03-28 2002-03-19 Compuestos farmaceuticalmente activos.
AU2002241211A AU2002241211A1 (en) 2001-03-28 2002-03-19 Imidazo-triazine derivatives as pde 5 inhibitors
BR0208463-5A BR0208463A (pt) 2001-03-28 2002-03-19 Compostos farmaceuticamente ativos
JP2002577827A JP2004528320A (ja) 2001-03-28 2002-03-19 医薬活性化合物
EP02707056A EP1395589A1 (en) 2001-03-28 2002-03-19 Imidazo-triazine derivatives as pde 5 inhibitors
CA002442329A CA2442329A1 (en) 2001-03-28 2002-03-19 Imidazo-triazine derivatives as pde 5 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0107751.0A GB0107751D0 (en) 2001-03-28 2001-03-28 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
GB0107751D0 true GB0107751D0 (en) 2001-05-16

Family

ID=9911744

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0107751.0A Ceased GB0107751D0 (en) 2001-03-28 2001-03-28 Pharmaceutically active compounds

Country Status (8)

Country Link
EP (1) EP1395589A1 (https=)
JP (1) JP2004528320A (https=)
AU (1) AU2002241211A1 (https=)
BR (1) BR0208463A (https=)
CA (1) CA2442329A1 (https=)
GB (1) GB0107751D0 (https=)
MX (1) MXPA03005990A (https=)
WO (1) WO2002079203A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
CA2462200A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7354923B2 (en) 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
DE10229778A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Neue Verwendung von Imidazotriazinonen
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
DK1697371T3 (da) * 2003-12-19 2007-09-17 Bristol Myers Squibb Co Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
TW200528455A (en) * 2003-12-19 2005-09-01 Bristol Myers Squibb Co Azabicyclic heterocycles as cannabinoid receptor modulators
US7683060B2 (en) 2006-08-07 2010-03-23 Incyte Corporation Triazolotriazines as kinase inhibitors
ME02372B (me) 2006-11-22 2016-06-20 Incyte Holdings Corp Imidazotriazini i imidazopiramidini kao inhibitori kinaze
WO2009143211A2 (en) 2008-05-21 2009-11-26 Incyte Corporation Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
EA025304B1 (ru) 2010-02-03 2016-12-30 Инсайт Холдингс Корпорейшн ИМИДАЗО[1,2-b][1,2,4]ТРИАЗИНЫ В КАЧЕСТВЕ c-Met ИНГИБИТОРОВ
CN102372730B (zh) * 2010-08-19 2014-03-26 山东轩竹医药科技有限公司 桥环取代的磷酸二酯酶抑制剂
CN102382129B (zh) * 2010-08-19 2014-02-26 山东轩竹医药科技有限公司 螺环取代的磷酸二酯酶抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6362178B1 (en) * 1997-11-12 2002-03-26 Bayer Aktiengesellschaft 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
US6503908B1 (en) * 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
DE10010067A1 (de) * 2000-03-02 2001-09-06 Bayer Ag Neue Imidazotriazinone und ihre Verwendung

Also Published As

Publication number Publication date
CA2442329A1 (en) 2002-10-10
BR0208463A (pt) 2004-03-02
JP2004528320A (ja) 2004-09-16
AU2002241211A1 (en) 2002-10-15
MXPA03005990A (es) 2005-02-14
EP1395589A1 (en) 2004-03-10
WO2002079203A1 (en) 2002-10-10
WO2002079203A8 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
EG24411A (en) Pharmaceutically active compounds
GB9924020D0 (en) Pharmaceutically active compounds
IL146117A0 (en) New pharmaceutically active compounds
HUP0400732A3 (en) Pharmaceutically active uridine esters
GB0101227D0 (en) Pharmaceutical compounds
GB0101225D0 (en) Pharmaceutical compounds
GB0107751D0 (en) Pharmaceutically active compounds
GB0105893D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
GB0112561D0 (en) Active plate
GB0017822D0 (en) Pharmaceutically active compound
GB0219897D0 (en) Pharmaceutically active compounds
GB0112563D0 (en) Active plate
GB0106651D0 (en) Pharmaceutically active compounds
GB0106561D0 (en) Pharmaceutically active compounds
GB0106562D0 (en) Pharmaceutically active compounds
GB0106629D0 (en) Pharmaceutically active compounds
GB0106617D0 (en) Pharmaceutically active compounds
GB9926630D0 (en) Pharmacologically active compounds
GB0219893D0 (en) Pharmaceutically active compounds
GB0007345D0 (en) Pharmaceutically active compounds
GB0018660D0 (en) Pharmaceutically active compounds
GB0018656D0 (en) Pharmaceutically active compounds
GB0219895D0 (en) Pharmaceutically active compounds
GB0105766D0 (en) Orally active compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)